| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.093 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |